Results about: mitochondria

<p>Antonio Zorzano, head of the Complex Metabolic Diseases and Mitochondria Lab</p>

Age-related metabolic diseases have increased to epidemic proportions in all industrialized countries.

Our research addresses the evolution of the protein synthesis machinery, the molecular interactions that regulate it, and the biomedical applications that can be derived from its study. Our research projects are focused around the biology of transfer RNA (tRNA).

La manca d’una única proteïna mitocondrial genera inflamació severa

El treball de l’IRB Barcelona obre la via a considerar que defectes en els mitocondris poden estar en l’origen d’un grup de malalties que impliquen inflamació muscular crònica i de les quals se’n desconeix l’origen.

Troben activadors d'una possible diana terapèutica pel tractament de pacients amb diabetis i resistència a la insulina

Un equip liderat per Antonio Zorzano a l'IRB Barcelona ha identificat activadors de la proteïna mitocondrial Mitofusina 2 pel tractament contra la diabetis de tipus 2.

La proteïna és un regulador clau de moltes de les funcions dels mitocondris, així com de la cèl·lula en el seu conjunt.

I still carry with me the passion IRB Barcelona sparked, says 2017 Alumnus of Excellence Marc Liesa

The 2017 IRB Barcelona Alumni of Excellence Award has gone to Marc Liesa, who obtained his PhD in 2008 in Antonio Zorzano’s Complex Metabolic Diseases and Mitochondria Laboratory. The award, established in 2016, acknowledges the excellence of former IRB Barcelona scientists and is given with the support of Eppendorf. Liesa visited the Institute on 5 May to receive the distinction. He talks about his science and shares some secrets of his success.